Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4740637> ?p ?o }
Showing triples 1 to 20 of
20
with 100 triples per page.
- Q4740637 subject Q7211373.
- Q4740637 abstract "Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.Amatuximab was developed by Morphotek, Inc.Amatuximab is also known as Anti-mesothelin monoclonal antibody MORAb-009. Amatuximab is an anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin (a protein that is made by some cancer cells) and stops the cells from dividing, and also called MORAb-009.".
- Q4740637 atcPrefix "none".
- Q4740637 casNumber "931402-35-6".
- Q4740637 wikiPageExternalLink dictionary?CdrID=543500.
- Q4740637 wikiPageWikiLink Q14914057.
- Q4740637 wikiPageWikiLink Q422248.
- Q4740637 wikiPageWikiLink Q4740637.
- Q4740637 wikiPageWikiLink Q7211373.
- Q4740637 wikiPageWikiLink Q79460.
- Q4740637 wikiPageWikiLink Q8054.
- Q4740637 atcPrefix "none".
- Q4740637 casNumber "931402".
- Q4740637 type ChemicalSubstance.
- Q4740637 type Drug.
- Q4740637 type ChemicalObject.
- Q4740637 type Thing.
- Q4740637 type Q8386.
- Q4740637 comment "Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.Amatuximab was developed by Morphotek, Inc.Amatuximab is also known as Anti-mesothelin monoclonal antibody MORAb-009. Amatuximab is an anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin (a protein that is made by some cancer cells) and stops the cells from dividing, and also called MORAb-009.".
- Q4740637 label "Amatuximab".